Verleihen Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth 166.00%
- Profit Growth 126.19%
- Ebitda 273.32%
- Net Worth 3.53%
- Total Assets 69.56%
About Verleihen Life Sciences
Verleihen Life Sciences Private Limited (VLSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 18 October 2018 (Six years and three months 23 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ramakant Yadav and Manju serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999DL2018PTC340743
-
Company No.
340743
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Oct 2018
-
Date of AGM
27 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Verleihen Life Sciences Private Limited offer?
Verleihen Life Sciences Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Nutritional Supplements, Protein Powder, Chocolate Protein Powder, Vitamin Tablets & Capsules, Methylcobalamin Tablets, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs.
Who are the key members and board of directors at Verleihen Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramakant Yadav
|
Director | 03-Aug-2019 | Current |
|
Manju
|
Director | 20-Nov-2019 | Current |
Financial Performance of Verleihen Life Sciences.
Verleihen Life Sciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 166% increase. The company also saw a substantial improvement in profitability, with a 126.19% increase in profit. The company's net worth moved up by a moderate rise of 3.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Verleihen Life Sciences?
Unlock access to Verleihen Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
V H Life Sciences Private LimitedRamakant Yadav and Manju are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Verleihen Life Sciences?
Verleihen Life Sciences has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Verleihen Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Verleihen Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
